High DNA-methyltransferase 3B expression predicts poor outcome in acute myeloid leukemia, especially among patients with co-occurring NPM1 and FLT3 mutations.

ABSTRACT:

SUBMITTER: Monteferrario D 

PROVIDER: S-EPMC4219473 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature